| Income Statement | 2025-06-30 | 2025-03-31 | ||
|---|---|---|---|---|
| Bargain purchase gain | 1,693 | - | ||
| Net loss before taxes | -16,688 | -962 | ||
| Income tax (expense) income | 138 | 2 | ||
| Deferred tax income (expense) | -1,693 | - | ||
| Net loss after taxes | -15,133 | -964 | ||
| Foreign currency translation adjustment | -11,791 | - | ||
| Loss and comprehensive loss | -26,924 | - | ||
| Net loss per share, basic | -0.74 | -0.37 | ||
| Net loss per share, diluted | -0.74 | -0.37 | ||
| Weighted average number of shares outstanding, basic | 20,401,138 | 2,605,843 | ||
| Weighted average number of shares outstanding, diluted | 20,401,138 | 2,605,843 | ||
SRx Health Solutions, Inc. (SRXH)
SRx Health Solutions, Inc. (SRXH)